Industrial epidemiology, which may be defined as the study, in defined groups of people, of disease which may be related to an industrial substance or process, can impact not only on disease prevention policy but also on such diverse activities as industrial and public relations, regulatory activity and toxicological experimentation. These were some of the subjects discussed at the meeting. British epidemiologists and occupational health physicians were joined by a number of American members of the Forum, three of whom presented papers.
Two of the presentations underlined the increasing importance of the international dimension in epidemiology. Sir Richard Doll described international collaboration in combining all the data on nickel processing. Analysis of the differences between outcomes of the various studies had enabled the suspect conditions of exposure to be clarified to a greater degree than was possible from the individual studies. Dr Lorenzo Simonato (World Health Organization International Agency for Research in Cancer) continued this theme with a paper on the Agency's role in pulling together relevant results from different countries, and in planning and supporting collaborative studies. Stainless steel welding and man-made mineral fibre production are among current projects, and work is in hand to examine the health of atomic power plant workers, workers in biological laboratories, and workers exposed to styrene. An important issue for the Agency is prioritization, because each such study is very labour intensive and time consuming.
Several speakers discussed the difficulties imposed on international collaboration by inconsistent national customs and laws, such as the confidential status of death certificates in most of Continental Western Europe. Epidemiologists within industry might be able to circumvent this constraint by negotiating, as in one international company, the prior agreement from particular groups of employees to allow disclosure of this information on death. Several of the papers discussed the all important issue of the maintenance of valid, retrievable records of people, health information and exposure data. Dr John Fox, (Chief Medical Statistician, Office of Population Censuses and Surveys (OPCS», spoke of his hopes for continuing the improvement in the quality of information from OPCS, especially through the longitudinal study begun in 1971. In this study, the progress of households in a 1% sample from that census is being followed by recording births, deaths and emigrations. Amongst the issues which it is intended to explore are the dimensions of the 'healthy worker effect', first noted over 100 years ago, occupational mobility, differences of mortality between occupations, and the impact of working during pregnancy on infant mortality. Clair Chilvers (Institute of Cancer Research) described an example of the use of the longitudinal study as a basis for a study of fertilizer workers. This project had been proposed along parallel lines as a geographical descriptive study, a formal industrial cohort study and a study based on the longitudinal sample.
Report of
The relative advantages of the different approaches were described and the results of the studies compared. Dr Fox also referred to the use of the National Health Service Central Registry to flag members of cohorts so that researchers can be informed of details of their deaths. It is proposed to computerize entries in this Register from 1989 onwards. Over 100 studies are at present being monitored by means of the Registry. Dr Bob Jones (Health and Safety Executive) described the role of a UK government department in the conduct of such studies. His department has a role in using epidemiology as a tool for the setting of standards. This involves the ability to discriminate between the public perception of the problem and the reality. By cooperating with industry and academic institutions via well established links, the HSE is able to provide continuity for long-term studies. This continuity of purpose has been an invaluable element in the resolution of such problems as {j-naphthylamine, asbestos, and vinyl chloride. Such experience can be used to develop the debate on such compounds as arsenic, antimony and trichloroethylene in a scientific, unemotional manner. Dr Frank Rose (Iel Paints International Business) discussed the implications for industry of an international approach to epidemiology. The need was to identify less and less clear-cut excess risks more and more rapidly. This would only be achieved by a carefully structured approach to the identification of hazard and the monitoring of risk. He suggested, as a way forward, the concept of epidemiological end-points which could be defined, measured and monitored in both exposed and unexposed groups of employees.
Dr Jane Teta (Union Carbide, USA) explained some of the reasons why epidemiologists are in increasing demand in industry. Epidemiologists have not just the role described in other presentations, they also take part in the risk assessment process and go out to explain their companies' policiesin risk communication exercises. They contribute to material safety data sheets, make summary risk analyses and undertake environmental epidemiology studies involving issues and people in the community as well as within the factory fence. Environmental epidemiology, in particular the issue of nuclear energy, was the subject of two separate papers by Dr Bill Fayerweather (Dupont, USA) and Professor Martin Gardner <Medical Research Council's Environmental Epidemiology Unit at Southampton). Both papers discussed the difficulty of obtaining data of sufficient quality to address adequately the concern about health effects in the neighbourhood of plants processing radioactive materials. Dr Fayerweather graphically illustrated the problem of finding a community that could be said to have the same spread of age, sex, ethnic and social grouping as that in the neighbourhood of the plant. He was also concerned about the apparent instability of leukaemia rates from one decade to the next, in any such communities. Professor Gardner described, in the form of a history, the carefully planned sequence of investigations that had been undertaken in the UK to study, essentially, the same problem. Dr Teta went on to describe how added responsibilities were placed on American industry by the Toxic Substance Control Act and the 1983 OSHA Hazard communications standard which required new information of a toxic risk to be reported within days of it first being identified. This procedure leaves very little time to check the accuracy ofthe findings and the logic of the conclusions drawn from them. Professional epidemiologists are also having to contend with the activities of persons not trained in the profession using very crude information processed on home computers to provide propaganda against industry. That the amateurs have achieved a measure of credibility may be because the industrial and public health professionals have failed to gain the confidence of the general public. This raised the possibility of considering some form of standard setting for epidemiological investigations following the example of Good Laboratory Practice (GLP) in toxicology.
The relative strengths of toxicological experiments conforming to GLP and epidemiology as practised at present were discussed in papers by Professor Paul Grasso (Robens Institute, Guildford) and Dr Bill Gaffey (Monsanto, USA). In looking for a meeting point for toxicology and epidemiology, Professor Grasso compared the effective collaboration of the two disciplines on such issues as {j-naphthylamine and vinyl chloride to the lack of agreement on such compounds as benzene, formaldehyde, saccharin and dioxin. Collaboration was based on toxicological investigation of mechanisms which could with some confidence be related to the effects seen in man. On the other hand, attempts to extrapolate from the outcome of a carcinogenicity assay based on an inappropriate dosing regime could only lead to confrontation, particularly if the epidemiological evidence was substantial and largely negative. Dr Gaffey dealt with the issue of negative epidemiology. To include such information in a risk assessment is difficult and controversial, but to exclude it is clearly absurd. He showed that the a priori decision not to conduct a study of low statistical power was quite different from the posteriori decision to ignore the negative outcome of such a study once it had actually been conducted. He argued that negativity was not a black or white question. Negativity could be quantified, and what mattered was how negative a study was. Referring to international collaboration, or so-called meta-analysis, he suggested that this would not become valid until there was an equal chance ofpositive and negative studies being published.
Membership of the Industrial Epidemiology Forum (IEF) is restricted to persons employed full-time on epidemiology within industry. It is, therefore, largely an American organization. Several working parties have been formed within IEF, and the last two papers at this joint meeting were devoted to British views of two of the working parties' activities. Dr Win Castle (ICI Pharmaceuticals) talked about adverse reactions to drugs, and Dr Michael Joffe (St Mary's Hospital, London) reviewed his experience with reproductive health questionnaires. Dr Castle illustrated that the problems she faced in monitoring adverse reactions to her company's drugs were very similar to those faced by members of IEF. In deciding what information to collect, from what sources, how to structure it and how to interpret it, she had to make pragmatic choices between several theoretically reasonable alternatives. Whether she has chosen well, only time will tell. Dr Joffe described the many pitfalls to be avoided in his There was no suggestion that bovine visna virus had been specifically looked for or found. It has been known for some time that bovine virus diarrhoea virus is a common contaminant of fetal calf serum".
Letters to the Editor
As far as we are aware there has been no report of the isolation of bovine visna virus from fetal calf serum. area of endeavour, in particular he was concerned to make his procedures acceptable to the workforce under study.
In the space of two days, the meeting covered a wide range of topics and aroused a great deal of discussion both after the presentations and during the breaks. One was left with the feeling that the era of international collaboration on industrial epidemiology is only just beginning and that there will be a need for the subject to be revisited in the not too distant future.
G M Paddle ICI Epidemiology Unit Macclesfield, Cheshire (Accepted 17 January 1989) 
Localization of insulinoma by intraoperative ultrasonography
London et at. (November 1988 JRSM, p 663) have emphasized the interest of intraoperative pancreatic ultrasonography to locate an occult, impalpable insulinoma and correctly suggested that such procedure can reduce the number of patients with pancreatic tumours who require a 'blind' pancreatic resection. We consider that intraoperative pancreatic ultrasonography must be systematically performed even when a tumour has been located preoperatively using standard imaging procedures. Insulinoma tumours are frequently multiple and removal of a single tumour located preoperatively does not always result in correction of hypoglycemia. A 63-year-old woman was recently referred to us for fasting hypoglycemia. An insulinoma was suspected on the basis of fasting hypoglycemia (2.0 mmolll)in the presence of inappropriately high levels ofplasnia insulin (37 mUll) and C-peptide (0.554 pmol/ml), Preoperative ultrasonography and arteriography were negative. CT-scan suggested the presence of a 15 mm diameter tumour in the middle of the gland. Laparotomy confirmed the presence of this tumour; preoperative ultrasonography not only showed the presence of the tumour but also revealed two small tumours (2-3 mm in diameter) more distally located. After caudal pancreatectomy, the patient completely recovered, blood glucose returned to normal and histology confirmed all three tumours to be insulinomas. Therefore, we suggest intraoperative ultrasonography to be performed systematically over the pancreatic gland even ifpreoperative imaging and peroperative palpation are concordant in localizing an insulinoma tumour.
Old age in Down's syndrome I read with interest the report of Demissie and his colleagues (December 1988 JRSM, p 740) on the longevity of a mosaic Down's syndrome female.
